I hope you have accidentally missed out the possibility of trial start coinciding with meaningful presentations on biomarkers and gene based patients selection.
I’d agree if we only get the analysis outcome presentations at AAIC, we could see a slam down on the news.
However, if backed up by start of one of the 12 week trials the following week, I would think there will be hectic buying probably with some profit taking prior to readout.
Tom, I spent some time looking at your chart and the geometry. It is certainly plausible. I see that 4.35 number as being of major significance on your chart as well. I sold my trading shares at 4.19 and am waiting for a pull back to around 3.44. If that does not happen and we go up through 4.35 on volume that would signal an impulsive wave III and I would buy back and not trade but hold for the long term.
If the big boys sense that this is for real the stock will explode much higher. I know you are not a big volume watcher but the footprints of big money are starting to show. I would not want to be short. The Russell rebalance could be a God send to whoever bought Friday. JMHO
News 
Market Data 
Discover 
